The Fox Chase Chemical Diversity Center, Inc. (FCCDC)

 

The Fox Chase Chemical Diversity Center Announces it Has Been Awarded a Phase I SBIR Grant Entitled "Trypanocidal Agents that Kill Multiple Stages of the Trypanosoma cruzi Life Cycle"

 

Doylestown, PA. July 17, 2020 - FCCDC is pleased to announce it has been awarded a Phase I SBIR from the NIH entitled "Trypanocidal Agents that Kill Multiple Stages of the Trypanosoma cruzi Life Cycle" (1R43AI152788-01A1).